About our Premium Reports
Our Premium Reports are specialized reports that are only available to active users with HealthTech Alpha Pro and HealthTech Alpha Enterprise accounts and are provided at no additional cost.
We are delighted to share with you our 2020 Asia Pac HealthTech Landscape Half Year report, the 7th edition of our bi-annual go-to-reference for ecosystem key trends and insights for investors, corporations and digital health ventures.
As we publish this report, the WHO reports that cases and deaths from COVID-19 have passed 11 million and over 500,000 deaths. It is a great stress test for healthcare systems across the world and for digital health investments.
Whilst Galen Growth has witnessed a significant shift in the adoption of digital health solutions to address weakened and, at times, inadequate healthcare systems, HealthTech has seen a substantial loss of investment momentum in H1 2020 which closed at US$1.9B invested, approximatively half of H1 2019, across 171 deals, a 46% dropped from last year first six months.
Our Premium Reports are specialized reports that are only available to active users with HealthTech Alpha Pro and HealthTech Alpha Enterprise accounts and are provided at no additional cost.
Galen Growth’s proprietary platform, HealthTech Alpha, provides the data source for this report. Corporate Business Development, Business Intelligence, and Digital Health Partnership teams worldwide prefer HealthTech Alpha, the world’s most-trusted Digital Health data, intel, and insights platform. Visit https://www.healthtechalpha.com to learn more about our data or https://www.galengrowth.com research for our reports.
Founded in 2016 by Digital Health experts, Galen Growth empowers global Fortune 500 companies, institutional investors, and promising Digital Health ventures to fast track their digital health strategy to create significant financial and social values. To find out more, visit https://www.galengrowth.com